173 related articles for article (PubMed ID: 20081813)
1. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.
Gaiser T; Kutzner H; Palmedo G; Siegelin MD; Wiesner T; Bruckner T; Hartschuh W; Enk AH; Becker MR
Mod Pathol; 2010 Mar; 23(3):413-9. PubMed ID: 20081813
[TBL] [Abstract][Full Text] [Related]
2. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases.
Vergier B; Prochazkova-Carlotti M; de la Fouchardière A; Cerroni L; Massi D; De Giorgi V; Bailly C; Wesselmann U; Karlseladze A; Avril MF; Jouary T; Merlio JP
Mod Pathol; 2011 May; 24(5):613-23. PubMed ID: 21151100
[TBL] [Abstract][Full Text] [Related]
3. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
Zembowicz A; Yang SE; Kafanas A; Lyle SR
Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
[TBL] [Abstract][Full Text] [Related]
4. Application of fluorescence in situ hybridization as a diagnostic tool in melanocytic lesions, using paraffin wax-embedded tissues and imprint-cytology specimens.
Abásolo A; Vargas MT; Ríos-Martín JJ; Trigo I; Arjona A; González-Cámpora R
Clin Exp Dermatol; 2012 Dec; 37(8):838-43. PubMed ID: 22731835
[TBL] [Abstract][Full Text] [Related]
5. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.
Pouryazdanparast P; Newman M; Mafee M; Haghighat Z; Guitart J; Gerami P
Am J Surg Pathol; 2009 Sep; 33(9):1396-400. PubMed ID: 19606012
[TBL] [Abstract][Full Text] [Related]
6. Comparison of melanoma gene expression score with histopathology, fluorescence in situ hybridization, and SNP array for the classification of melanocytic neoplasms.
Reimann JDR; Salim S; Velazquez EF; Wang L; Williams KM; Flejter WL; Brooke L; Sunder S; Busam KJ
Mod Pathol; 2018 Nov; 31(11):1733-1743. PubMed ID: 29955141
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation.
Morey AL; Murali R; McCarthy SW; Mann GJ; Scolyer RA
Pathology; 2009; 41(4):383-7. PubMed ID: 19404853
[TBL] [Abstract][Full Text] [Related]
8. [Ancillary values of fluorescence in situ hybridization with different gene combination in diagnosis of malignant melanoma].
Ren M; Bai QM; Kong YY; Zhou XY; Chang H; Cai X
Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):827-833. PubMed ID: 32746551
[No Abstract] [Full Text] [Related]
9. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.
Gerami P; Jewell SS; Morrison LE; Blondin B; Schulz J; Ruffalo T; Matushek P; Legator M; Jacobson K; Dalton SR; Charzan S; Kolaitis NA; Guitart J; Lertsbarapa T; Boone S; LeBoit PE; Bastian BC
Am J Surg Pathol; 2009 Aug; 33(8):1146-56. PubMed ID: 19561450
[TBL] [Abstract][Full Text] [Related]
10. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization.
Busam KJ; Fang Y; Jhanwar SC; Pulitzer MP; Marr B; Abramson DH
J Cutan Pathol; 2010 Feb; 37(2):196-203. PubMed ID: 20100177
[TBL] [Abstract][Full Text] [Related]
11. Differentiation of malignant melanoma from benign nevus using a novel genomic microarray with low specimen requirements.
Chandler WM; Rowe LR; Florell SR; Jahromi MS; Schiffman JD; South ST
Arch Pathol Lab Med; 2012 Aug; 136(8):947-55. PubMed ID: 22849744
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in-situ hybridization analysis for melanoma diagnosis.
Senetta R; Paglierani M; Massi D
Histopathology; 2012 Apr; 60(5):706-14. PubMed ID: 22007736
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.
Mudhar HS; Smith K; Talley P; Whitworth A; Atkey N; Rennie IG
Br J Ophthalmol; 2013 Jan; 97(1):40-6. PubMed ID: 23137666
[TBL] [Abstract][Full Text] [Related]
14. Nevus versus melanoma: to FISH, or not to FISH.
Song J; Mooi WJ; Petronic-Rosic V; Shea CR; Stricker T; Krausz T
Adv Anat Pathol; 2011 May; 18(3):229-34. PubMed ID: 21490440
[TBL] [Abstract][Full Text] [Related]
15. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.
Gerami P; Li G; Pouryazdanparast P; Blondin B; Beilfuss B; Slenk C; Du J; Guitart J; Jewell S; Pestova K
Am J Surg Pathol; 2012 Jun; 36(6):808-17. PubMed ID: 22588064
[TBL] [Abstract][Full Text] [Related]
16. Molecular testing of borderline cutaneous melanocytic lesions: SNP array is more sensitive and specific than FISH.
Carter MD; Durham AB; Miedema JR; Harms PW; Chan MP; Patel RM; Lowe L; Fullen DR; Hristov AC; Wang M; Andea AA
Hum Pathol; 2019 Apr; 86():115-123. PubMed ID: 30576704
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
[TBL] [Abstract][Full Text] [Related]
18. The correlation of the standard 5 probe FISH assay with melanocytic tumors of uncertain malignant potential.
Muhlbauer A; Momtahen S; Mihm MC; Wang J; Magro CM
Ann Diagn Pathol; 2017 Jun; 28():30-36. PubMed ID: 28648937
[TBL] [Abstract][Full Text] [Related]
19. Fluorescence in-situ hybridization and dermoscopy in the assessment of controversial melanocytic tumors.
Ponti G; Ruini C; Massi D; Pellacani G; Tomasi A; Paglierani M; Loschi P; Seidenari S
Melanoma Res; 2013 Dec; 23(6):474-80. PubMed ID: 24077512
[TBL] [Abstract][Full Text] [Related]
20. Fluorescence in situ hybridization for ambiguous melanocytic tumors.
Gammon B; Gerami P
Histol Histopathol; 2012 Dec; 27(12):1539-42. PubMed ID: 23059884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
